Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (scFv-IgG)  (BSSG-142)

Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CEA antibody variable domain are respectively connected to the N terminus of the anti-TNFα IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget cytokine (TNFα) to tumor cells. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.

Datasheet